The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A nationwide double-blind phase III randomized clinical trial (RCT) of olanzapine vs. prochlorperazine for the treatment of refractory nausea in patients receiving moderately or highly emetogenic chemotherapy among NCI Community Oncology Research Program (NCORP) practices.
 
Luke Joseph Peppone
Consulting or Advisory Role - Ajna Biosciences
 
Chunkit Fung
Consulting or Advisory Role - Exelixis; Novartis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Joseph John Guido
No Relationships to Disclose
 
Gary R. Morrow
No Relationships to Disclose
 
Michelle Christine Janelsins
No Relationships to Disclose
 
Kathleen J. Yost
Stock and Other Ownership Interests - Pfizer (I)
Research Funding - Pfizer
Other Relationship - AstraZeneca; Natera; Pfizer
 
Belal Firwana
No Relationships to Disclose
 
Joseph Roscoe
No Relationships to Disclose
 
Eva Culakova
No Relationships to Disclose